Showing results (71-80 of 313) with videos related to

Sort By:
Pageof 32
Haematologica|August 6, 2002
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromesGuillermo Garcia-Manero, Stefan Faderl, Francis Giles, et al.
Cancer|October 11, 2008
Outcome of adults with acute lymphocytic leukemia after second salvage therapySusan O'Brien, Deborah Thomas, Farhad Ravandi, et al.
Leukemia & Lymphoma|March 4, 2010
Late relapses in acute myeloid leukemia: analysis of characteristics and outcomeDushyant Verma, Hagop Kantarjian, Stefan Faderl, et al.
Haematologica|April 26, 2012
Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemiaAziz Nazha, Jorge Cortes, Stefan Faderl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemiasVarsha Gandhi, Hagop Kantarjian, Stefan Faderl, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2012
Prognostic factors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabineElias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.
Leukemia & Lymphoma|January 19, 2010
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remissionHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Cancer|October 26, 2007
Low serum albumin level is associated with cytomegalovirus reactivation in patients with chronic lymphoproliferative diseases treated with alemtuzumab (Campath-1H)-based therapiesGautam Borthakur, E Lin, Stefan Faderl, et al.
Pageof 32